Nectar Lifesciences Limited

NSE:NECLIFE India Drug Manufacturers - Specialty & Generic
Market Cap
$28.36 Million
₹2.46 Billion INR
Market Cap Rank
#26989 Global
#1439 in India
Share Price
₹10.95
Change (1 day)
-1.26%
52-Week Range
₹10.95 - ₹27.17
All Time High
₹59.47
About

Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and internationally. The company offers cephalosporins, includes pharmaceutical ingredients and intermediates comprising cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil an… Read more

Nectar Lifesciences Limited (NECLIFE) - Total Liabilities

Latest total liabilities as of September 2025: ₹10.98 Billion INR

Based on the latest financial reports, Nectar Lifesciences Limited (NECLIFE) has total liabilities worth ₹10.98 Billion INR as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Nectar Lifesciences Limited - Total Liabilities Trend (2006–2025)

This chart illustrates how Nectar Lifesciences Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Nectar Lifesciences Limited Competitors by Total Liabilities

The table below lists competitors of Nectar Lifesciences Limited ranked by their total liabilities.

Company Country Total Liabilities
Pamel Yenilenebilir Elektrik Uretim AS
IS:PAMEL
Turkey TL318.59 Million
KWANGJIN WINTEC CO. Ltd
KQ:090150
Korea ₩81.45 Billion
ACCESS Newswire Inc.
NYSE MKT:ACCS
USA $13.26 Million
Thiogenesis Therapeutics Corp.
V:TTI
Canada CA$1.47 Million
Samhwa Networks Co. Ltd
KQ:046390
Korea ₩38.95 Billion
Kocom Co. Ltd
KQ:015710
Korea ₩23.97 Billion
Bakrie & Brothers Tbk
JK:BNBR
Indonesia Rp18.90 Trillion
PT Boston Furniture Industries Tbk
JK:SOFA
Indonesia Rp15.20 Billion

Liability Composition Analysis (2006–2025)

This chart breaks down Nectar Lifesciences Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.36 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.01 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.53 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.60 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nectar Lifesciences Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nectar Lifesciences Limited (2006–2025)

The table below shows the annual total liabilities of Nectar Lifesciences Limited from 2006 to 2025.

Year Total Liabilities Change
2025-03-31 ₹10.91 Billion -2.74%
2024-03-31 ₹11.22 Billion -0.25%
2023-03-31 ₹11.25 Billion -13.69%
2022-03-31 ₹13.03 Billion -7.53%
2021-03-31 ₹14.09 Billion -5.88%
2020-03-31 ₹14.97 Billion -6.42%
2019-03-31 ₹16.00 Billion -3.92%
2018-03-31 ₹16.65 Billion +5.78%
2017-03-31 ₹15.74 Billion -1.75%
2016-03-31 ₹16.02 Billion +3.20%
2015-03-31 ₹15.53 Billion +5.83%
2014-03-31 ₹14.67 Billion +4.31%
2013-03-31 ₹14.06 Billion +5.24%
2012-03-31 ₹13.36 Billion +22.44%
2011-03-31 ₹10.91 Billion +26.94%
2010-03-31 ₹8.60 Billion -12.46%
2009-03-31 ₹9.82 Billion +47.82%
2008-03-31 ₹6.65 Billion +19.46%
2007-03-31 ₹5.56 Billion +112.82%
2006-03-31 ₹2.61 Billion --